Acne Vulgaris: Nelson P. Tandayu 0 9 - 1 0 0
Acne Vulgaris: Nelson P. Tandayu 0 9 - 1 0 0
Acne Vulgaris: Nelson P. Tandayu 0 9 - 1 0 0
N E L S O N P. TA N D AY U 09-100
FA K U LTA S K E D O K T E R A N U N I V E R S I TA S K R I S T E N I N D O N E S I A
DEFINITION
Acne vulgaris is a self-limited disorder of the pilosebaceous unit that is seen primarily in adolescents.
Zaenglein et al, 2008.
PILOSEBACEOUS UNIT
LESION (1)
Cases of acne present with a pleomorphic variety of lesions, consisting of comedones, papules, pustules, and nodules.
LESION (2)
Although the course of acne may be self-limiting, the sequelae can be lifelong, with pitted or hypertrophic scar formation
EPIDEMIOLOGY
Acne is often an early manifestation of puberty The greatest numbers of cases are seen during the middle-to-late teenage period. Afterward, the incidence steadily decreases.
ETIOLOGY
Normal physiological reaction in puberty Disease of the ovaries
Polycystic ovarian syndrome Benign or malignant ovarian tumors
ETIOLOGY
INITIAL PATHOGENESIS: follicular hyperkeratinization proliferation + decreased desquamation of keratinocytes hyperkeratotic plug (microcomedone)
PATHOGENESIS
Bacteria thrive Inflammation results Chemotactic factors attract neutrophils Depending on conditions
Non-inflammatory open/closed comedones Inflammatory papule/pustule/nodule
1. FOLLICULAR PLUGGING
Proliferation of ductal keratinocytes, with altered differentiation Result in comedones First observed at adrenarchy Probably androgen mediated
3. BACTERIAL OVERGROWTH Colonization with Proprionibacterium acnes Normal commensal, anaerobic Increased growth in blocked sebumfilled follicles
4. INFLAMMATION Mediated by activation of monocytes and neutrophils by P. acnes Release of inflammatory cytokines
Interleukins TNF
GRADING
Plewig & Kligman (1975)1: Comedones: <10 comedones on 1 side of the face 10-24 comedones 25-50 comedones >50 comedones Papulopustular lesions: <10 papulopustular lesions on 1 side of the face 10-20 papulopustular lesions 21-30 papulopustular lesions >30 papulopustular lesions
Wasitaatmadja (1982)1: Ringan, bila: Beberapa lesi tak beradang pada 1 predileksi Sedikit lesi tak beradang pada beberapa tempat predileksi Sedikit lesi beradang pada 1 predileksi Sedang, bila: Banyak lesi tak beradang pada 1 predileksi Beberapa lesi tak beradang pada lebih dari 1 predileksi Beberapa lesi beradang pada 1 predileksi Sedikit lesi beradang pada lebih dari 1 predileksi Berat, bila: Banyak lesi tak beradang pada lebih dari 1 predileksi Banyak lebih beradang pada 1 atau lebih predileksi
CLOSE UP OF BLACKHEAD
INFLAMMATORY LESIONS Papules (small red bumps) Pustules (white or yellow squeezable spots) Inflamed nodules (large red lumps)
ACNE CONGLOBATA
Unpleasant form of nodulocystic acne Interconnecting abscesses and sinuses, which result in unsightly hypertrophic (thick) and atrophic (thin) scars. There are groups of large macrocomedones and cysts that are filled with smelly pus.
WHAT TESTS SHOULD BE DONE? In general, laboratory workup is not indicated for patients with acne unless hyperandrogenism is suspected. Many patients report that their acne flares during periods of stress.
DIFFERENTIAL DIAGNOSIS
ACNEIFORM ERUPTION
A drug induced acne.
Prevention
Treatment
PREVENTION OF ACNE
Avoid the increasing amount of lipid sebum Avoid the triggering factors of acne Inform consent
TREATMENT OF ACNE
Topical Systemic
Physical
Diet
TOPICAL MEDICATION
Retinoid (tretinoin 0.1-0.25%, isotretinoin 0.05%, adapalene 0.1%)
Benzoyl peroxide
a powerful antimicrobial agent. This effect is related
TOPICAL ANTIBIOTICS
Clindamycin 1% Erythromycin 2% or 4% with zinc acetate 1.2% most useful when inflammatory lesions predominate
SYSTEMIC MEDICATIONS
ORAL ANTIBIOTICS
1st line - Tetracycline, doxycycline, minocycline
2nd line - Erythromycin Cotrimoxazole
PHYSICAL TREATMENT Comedones extraction Intralesion corticosteroids Liquid nitrogen Ultraviolet radiation
REFERENCES
Djuanda A, Hamzah M, Aisah S, editor. Ilmu penyakit kulit dan kelamin. Edisi keenam. Jakarta: Badan Penerbit FKUI; 2013. Hal. 254-9. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ. Fitzpatrick's dermatology in general medicine. 7th Ed. New York: McGraw-Hill; 2008. p. 692-702. Buxton PK. ABC of dermatology. 4th Ed. London: BMJ Group; 2003. p. 47-9.
Weller R, Hunter J, Savin J, Dahl M. Clinical Dermatology. 4th Ed. UK: Blackwell Publishing; 2008. p. 16270.
Batra, Sonia. Acne. In: Ardnt KA, Hsu JT, editor. Manual of dermatology therapeutics. 7th Ed. Massachusetts: Lippincot Williams and Wilkins; 2007. p. 4-18. Schalock PC. Rosaceae and perioral (periorificial) dermatitis. In: Ardnt KA, Hsu JT, editor. Manual of dermatology therapeutics. 7th Ed. Massachusetts: Lippincot Williams and Wilkins; 2007. p.175-180 Dreno B, Poli F. Epidemiology of Acne. Dermatology, Acne Symposium at the World Congres of Dermatology Paris July 2002. p.7-9.
James WD, Berger TG, Elston DM. Acne. In: James W, Berger T, ElstonDM, editor. Andrews disease of the skin Clinical Dermatology 10th Ed. Canada: Elsevier; 2000. p. 231-44.
Gupta AK, Swan JE. Perioral dermatitis. In: Williams H, Bigbi MC, Diepgen T, Herxheimer H, Nalgi L, Rzany B. Evidence-Based Dermatology. London: BMJ Books; 2003. p. 125-131. Webster, Guy. Overview of the pathogenesis of acne. In: Webster GF, Rawlings AV, editor. Acne and its therapy. London:Informa Healthcare; 2007. p. 1-5. Zouboulis, Christos C. Update and future of systemic acne treatment. Dermatology, Acne Symposium at the World Congres of Dermatology Paris July 2002. p. 37-42.